Supernus Pharmaceuticals | Umsatzkosten



Cost Of Sales Veränderung Datum
Abbott USD 4.44B 502M 2025-03
ANI Pharmaceuticals USD 73.04M 7.24M 2025-03
Aurora Cannabis CAD 78.85M 891K 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 2.4M 553K 2025-03
Eisai JPY 40.6B 5.33B 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Indivior 44M 21M 2025-03
Novo Nordisk 12.89B 1.58B 2025-03
Pacira USD 34.31M 5.58M 2025-03
Perrigo USD 651.6M 100.8M 2025-03
Pfizer USD 2.59B 3.06B 2025-03
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
United Therapeutics USD 277.5M 201.6M 2025-03
Xeris Pharmaceuticals USD 9.48M 4.12M 2024-12



Supernus Pharmaceuticals Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.